Ignite Creation Date:
2024-05-06 @ 1:14 AM
Last Modification Date:
2024-10-26 @ 11:01 AM
Study NCT ID:
NCT01767129
Status:
COMPLETED
Last Update Posted:
2022-04-29
First Post:
2013-01-09
Brief Title:
Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinsons Disease Patients
Sponsor:
Avanir Pharmaceuticals
Organization:
Avanir Pharmaceuticals
Organization Data
Organization:
Avanir Pharmaceuticals
Class:
INDUSTRY
Study ID:
12-AVR-133
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Avanir Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Michael J Fox Foundation for Parkinsons Research | OTHER |